Drug Shortage Report for CISATRACURIUM BESYLATE INJECTION
| Report ID | 1428 |
| Drug Identification Number | 02425718 |
| Brand name | CISATRACURIUM BESYLATE INJECTION |
| Common or Proper name | Cisatracurium Besylate |
| Company Name | PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CISATRACURIUM |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 20 mg/10 mL x 10 |
| ATC code | M03AC |
| ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2015-07-30 |
| Estimated end date | Unknown |
| Actual end date | 2019-03-25 |
| Shortage status | Resolved |
| Updated date | 2019-03-28 |
| Company comments | Product is discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-03-28 | French | Compare |
| v5 | 2019-03-28 | English | Compare |
| v4 | 2017-03-14 | French | Compare |
| v3 | 2017-03-14 | English | Compare |
| v2 | 2017-03-13 | French | Compare |
| v1 | 2017-03-13 | English | Compare |
Showing 1 to 6 of 6